During the past decade, St. Luke's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 73 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 48 trials, followed by "National Cancer Institute (NCI)" with 32 trials sponsored, "Eastern Cooperative Oncology Group" with 7 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored and "Radiation Therapy Oncology Group" with 7 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 78 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "North Central Cancer Treatment Group" with 8 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Hospital" are "Breast Cancer" (26 trials), "Lung Cancer" (12 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials), "Lymphoma" (5 trials) and "Pancreatic Cancer" (5 trials). Many other conditions were trialed in "St. Luke's Hospital" in a lesser frequency.

Most popular intervention types in "St. Luke's Hospital" are "Drug" (95 trials), "Other" (51 trials), "Biological" (46 trials), "Radiation" (15 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "placebo" (20 trials), "Bevacizumab" (12 trials), "bevacizumab" (10 trials) and "radiation therapy" (9 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Hospital" are 83 trials for "All" genders, 25 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "St. Luke's Hospital". undefined are not yet recruiting, undefined are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 87 completed trials in St. Luke's Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Hospital, 3 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".